FDA Warning Letter Explorer
Medical Devices · Dec 16, 2025

GenderBender LLC

1 extracted findings · 1 model-assigned issue type

FDA source excerpt, selected passage

Our records indicate that you have not registered or listed these devices for fiscal year 2026.

FDA published a close-out letter on Apr 2, 2026. The findings below are from the original warning letter.

Findings and supporting evidence

Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.

Registration, listing & premarket

The firm failed to register and list its breast binder devices with FDA.

Supporting FDA text
Source excerpt · automated text-match check

Our records indicate that you have not registered or listed these devices for fiscal year 2026.

Findings extracted from the letter

Selected FDA passages, not the complete letter.

01
Our records indicate that you have not registered or listed these devices for fiscal year 2026.

Source passage selected by the model

What FDA requested

Model-assisted summary. Consult the letter for complete requests and conditions.

  • Register establishment and list devices with FDA
  • Provide written response within fifteen business days detailing corrections
  • Explain how firm plans to prevent future violations
  • Include documentation of corrections and corrective actions
  • Provide timetable for implementation if corrections take time
  • State reason for delay if corrections cannot be completed in fifteen days
Keep exploring

More medical-device letters

Recent records for the same product type. Your previous filters remain available when you return.

Keep exploring

For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.